0.01
-9.09%
Close of 6 Nov 2026, in AUD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About TrivarX
Its shares trade on ASX under the ticker TRI.AX. It has been listed since 29 January 2001. In the fiscal year to 30 June 2025, it reported revenue of A$1.1m and a net loss of A$943,231. At that date it held total assets of A$13.5m and shareholders' equity of A$12.7m.
TrivarX Ltd is a AU-based company operating in Health Care Technology industry. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2001-01-29. TrivarX Limited, formerly Medibio Limited, is an Australia-based mental health technology company engaged in the use of objective measures to aid in the early detection and screening of mental health conditions. Through the Company’s corporate health product, it offers mental well-being solutions for businesses and is also developing products to serve the healthcare provider market. The principal activity of the Company is conducting clinical research, product development and early-stage commercialization of a mental health technology using objective biomarkers to assist in the screening, diagnosing, monitoring, and management of depression and other mental health conditions. The company has launched its consumer mobile application to help measure, monitor, and manage stress, called LUCA. LUCA is a biometric assessment tool that measures sleep stress, activity stress, and cardiac stress that allows consumers to monitor their daily stress levels through their own personal wearable device.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Technology
- Listed since
- 29 Jan 2001
- Website
- medibio.com.au ↗
Leadership
Pay as last reported
- Mr. David TrimboliNon-Executive Independent Chairman of the Board
- Mr. Brian MowerChief Financial Officer
- Mr. Jeremy SchroetterChief Technology Officer
- Dr. Tony KeatingExecutive Director, since 2024
- Dr. Archie DefilloChief Medical Officer
- S. StapelbergMarketing ExecutiveA$20,000
- Mr. Stephen BuckleyCompany Secretary
- Dr. Lisa IdeNon-Executive Director
- Mr. John MathiasNon-Executive Director
- Mr. Christopher NtoumenopoulosNon-Executive Director
- Ms. Liwanag OjalaNon-Executive Director
- Ms. Lisa Wipperman HeineNon-Executive Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- TrivarX Ltd operates in the Health Care Technology industry with a focus on mental health solutions.
- The company launched LUCA, a consumer mobile application for measuring and managing daily stress levels.
- TrivarX uses objective biomarkers to assist in the screening and diagnosing of depression conditions.
Weaknesses
- The company is headquartered in South Melbourne, Victoria, which may limit its immediate global reach.
- TrivarX Limited was formerly known as Medibio Limited, indicating a past rebranding effort.
- The firm focuses on early-stage commercialization, suggesting its products are not yet fully mature.
Opportunities
- TrivarX is developing products specifically to serve the healthcare provider market segment.
- The corporate health product offers mental well-being solutions for businesses seeking employee support.
- Objective measures aid in the early detection of mental health conditions for broader adoption.
Threats
- The company went public on 29 January 2001, facing long-term market volatility risks.
- TrivarX operates in Australia, a specific country with unique regulatory health care requirements.
- Dependence on wearable devices for data collection may limit user accessibility and adoption rates.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.